Targeting the Undruggable KRAS Mutation in Lung Cancer: A Review
Premier Journal of Science · 2024
DOI: 10.70389/pjs.100001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Premier Journal of Science, 2024. Verfasst von Clark Jones. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Targeting the KRAS mutation in lung cancer has proven to be a challenging yet essential task due to its intricate signaling mechanisms and high prevalence in non-small cell lung cancer (NSCLC). Despite historical setbacks, recent advancements have led to the approval of targeted therapies such as sotorasib and adagrasib, offering new hope for patients with KRAS-mutated lung cancer. Ongoing research and development efforts have introduced several promising candidates in the pipeline, showcasing promising compounds like a pan-KRAS inhibitor, which could potentially transform the treatment landscape for KRAS-mutant cancers. Artificial intelligence (AI) in accelerating drug discovery for KRAS-targeted therapies, leveraging machine learning algorithms to analyze vast amounts of data and predict the efficacy of potential drug candidates. AI- driven drug discovery is revolutionizing the field by enabling researchers to explore novel treatment strategies and develop innovative therapies for KRAS-mutant cancers. AI may be utilized to develop personalized treatment regimens, predict outcomes, and revolutionize the landscape of precision medicine for lung cancer patients with KRAS mutations. Through a combination of cutting-edge research, combination therapies, and AI-driven innovation, recent advancements illustrate profound hope in the field of targeting the historically undruggable KRAS mutation in lung cancer.
Zitieren
APA
Jones, C. (2024). Targeting the Undruggable KRAS Mutation in Lung Cancer: A Review. Premier Journal of Science. https://doi.org/10.70389/pjs.100001
Vancouver
Jones C. Targeting the Undruggable KRAS Mutation in Lung Cancer: A Review. Premier Journal of Science. 2024. doi:10.70389/pjs.100001
BibTeX
@article{Jones2024,
author = {Jones, Clark},
title = {Targeting the Undruggable KRAS Mutation in Lung Cancer: A Review},
journal = {Premier Journal of Science},
year = {2024},
doi = {10.70389/pjs.100001}
}
EUVIMED